These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33825059)

  • 121. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
    Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
    Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Stereotactic Radiofrequency Ablation for Metastatic Melanoma to the Liver.
    Bale R; Schullian P; Schmuth M; Widmann G; Jaschke W; Weinlich G
    Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1128-35. PubMed ID: 27055850
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Stereotactic Radiofrequency Ablation for Breast Cancer Liver Metastases.
    Bale R; Richter M; Dünser M; Levy E; Buchberger W; Schullian P
    J Vasc Interv Radiol; 2018 Feb; 29(2):262-267. PubMed ID: 29273283
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Correction to: Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Laimer G; Jaschke N; Schullian P; Putzer D; Eberle G; Solbiati M; Solbiati L; Goldberg SN; Bale R
    Eur Radiol; 2022 Jan; 32(1):737. PubMed ID: 34142222
    [No Abstract]   [Full Text] [Related]  

  • 125. Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.
    Cui R; Yu J; Kuang M; Duan F; Liang P
    J Cancer Res Ther; 2020; 16(2):379-386. PubMed ID: 32474527
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy.
    Schullian P; Putzer D; Eberle G; Laimer G; Bale R
    J Vasc Interv Radiol; 2020 Jun; 31(6):943-952. PubMed ID: 32414570
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
    Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
    Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
    [No Abstract]   [Full Text] [Related]  

  • 131. Resection of liver metastases from breast cancer: a multicentre analysis.
    He X; Zhang Q; Feng Y; Li Z; Pan Q; Zhao Y; Zhu W; Zhang N; Zhou J; Wang L; Wang M; Liu Z; Zhu H; Shao Z; Wang L
    Clin Transl Oncol; 2020 Apr; 22(4):512-521. PubMed ID: 31230220
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers.
    Bale R; Schullian P; Eberle G; Putzer D; Zoller H; Schneeberger S; Manzl C; Moser P; Oberhuber G
    Hepatology; 2019 Sep; 70(3):840-850. PubMed ID: 30520063
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison.
    Ruiz A; van Hillegersberg R; Siesling S; Castro-Benitez C; Sebagh M; Wicherts DA; de Ligt KM; Goense L; Giacchetti S; Castaing D; Morère J; Adam R
    Eur J Cancer; 2018 May; 95():1-10. PubMed ID: 29579478
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Cancer statistics, 2018.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System.
    Filippiadis DK; Binkert C; Pellerin O; Hoffmann RT; Krajina A; Pereira PL
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1141-1146. PubMed ID: 28584945
    [TBL] [Abstract][Full Text] [Related]  

  • 137. 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
    Cardoso F; Costa A; Senkus E; Aapro M; André F; Barrios CH; Bergh J; Bhattacharyya G; Biganzoli L; Cardoso MJ; Carey L; Corneliussen-James D; Curigliano G; Dieras V; El Saghir N; Eniu A; Fallowfield L; Fenech D; Francis P; Gelmon K; Gennari A; Harbeck N; Hudis C; Kaufman B; Krop I; Mayer M; Meijer H; Mertz S; Ohno S; Pagani O; Papadopoulos E; Peccatori F; Penault-Llorca F; Piccart MJ; Pierga JY; Rugo H; Shockney L; Sledge G; Swain S; Thomssen C; Tutt A; Vorobiof D; Xu B; Norton L; Winer E
    Ann Oncol; 2017 Jan; 28(1):16-33. PubMed ID: 28177437
    [No Abstract]   [Full Text] [Related]  

  • 138. The safety and effectiveness of liver resection for breast cancer liver metastases: A systematic review.
    Fairhurst K; Leopardi L; Satyadas T; Maddern G
    Breast; 2016 Dec; 30():175-184. PubMed ID: 27764727
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Ten-year survival in women with primary stage IV breast cancer.
    Eng LG; Dawood S; Sopik V; Haaland B; Tan PS; Bhoo-Pathy N; Warner E; Iqbal J; Narod SA; Dent R
    Breast Cancer Res Treat; 2016 Nov; 160(1):145-152. PubMed ID: 27628191
    [TBL] [Abstract][Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.